Filing Details
- Accession Number:
- 0001209191-22-019254
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-16 16:44:12
- Reporting Period:
- 2022-03-15
- Accepted Time:
- 2022-03-16 16:44:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
708818 | Nextgen Healthcare Inc. | NXGN | Services-Computer Integrated Systems Design (7373) | 952888568 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1813060 | David Ahmadzai | 3525 Piedmont Rd., Ne Building 6, Suite 700 Atlanta GA 30305 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-03-15 | 3,250 | $16.37 | 47,772 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2022-03-15 | 3,000 | $16.83 | 50,772 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-03-15 | 6,250 | $19.55 | 44,522 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2022-03-15 | 3,250 | $0.00 | 3,250 | $16.37 |
Common Stock | Stock Option (right to buy) | Disposition | 2022-03-15 | 3,000 | $0.00 | 3,000 | $16.83 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,000 | 2025-06-13 | No | 4 | M | Direct | |
3,000 | 2026-06-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.55 to$19.561. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholdersupon request.
- Original grant of 13,000 options granted on 6/13/2017 vested in four equal, annual installments beginning 6/13/2018.
- Original grant of 12,000 options granted on 5/30/2018 vests in four equal, annual installments beginning 6/1/2019. Options exercised vested on 6/1/2021. Remaining 3,000 options will vest on 6/1/2022.